Cancer cell mitochondria confer apoptosis resistance and promote metastasis

Area of Science:

• Mitochondrial biology
• Cancer research
• Genetics

Background:

• Mutations in mitochondrial DNA (mtDNA) are prevalent in various cancers.
• The specific role of cancer cell mutant mtDNA in tumorigenesis requires further investigation.

Purpose of the Study:

• To investigate the functional impact of cancer cell mutant mtDNA on tumorigenesis, focusing on apoptosis resistance and metastatic potential.
• To characterize mutations in breast cancer cell line mitochondrial genomes and their functional consequences.

Main Methods:

• Sequencing of the entire mitochondrial genome from three breast cancer cell lines (MCF7, MDA-MB-231, MDA-MB-435).
• Generation of mutant and wild-type cybrids by repopulating rho(0) cells with donor mtDNA.
• Assessment of mitochondrial membrane potential, reactive oxygen species (ROS) production, and apoptosis resistance.
• Evaluation of metastatic potential using a tail-vein mouse model and analysis of the PI3/Akt pathway.

Main Results:

• All three breast cancer cell lines harbored mtDNA mutations, with MDA-MB-435 showing a mutation in tRNA(Leu(CUN)).
• Mutant mtDNA increased mitochondrial membrane potential without a corresponding rise in ROS.
• Mutant mtDNA conferred resistance to etoposide-induced apoptosis and significantly increased metastatic potential in a mouse model.
• Mutant mtDNA constitutively activated the PI3/Akt pathway, contributing to enhanced metastasis.

Conclusions:

• Mutant mtDNA derived from cancer cells promotes apoptotic resistance and enhances metastatic capabilities.
• The findings highlight mutant mtDNA as a potential driver of cancer progression and metastasis, mediated partly by PI3/Akt pathway activation.